Related Experiment Video
Updated: Jul 6, 2025

Acquisition of Resting-State Functional Magnetic Resonance Imaging Data in the Rat
Published on: August 28, 2021
Dexmedetomidine Utilization During Air Medical Transport for Agitated Patients
David J Watson1, Erik Nemecek1, Russ Bongiovanni1
1Angel MedFlight Worldwide Air Ambulance Service, Scottsdale, AZ.
Dexmedetomidine may improve care for patients with traumatic brain injuries during long-distance air ambulance transport. This sedative offers a safer, more effective option for agitated patients in unique aviation environments.
Area of Science:
- Emergency Medicine
- Neuroscience
- Pharmacology
Background:
- Fixed-wing air ambulances frequently transport patients experiencing agitation due to traumatic brain injury (TBI) sequelae.
- Current transport protocols are limited by the availability of medications and equipment typically found in ground-based or short-distance vehicles.
- The unique environmental stressors of air medical transport can exacerbate patient agitation and complicate care.
Purpose of the Study:
- To evaluate the potential of dexmedetomidine as a safe and effective sedative agent for agitated TBI patients during fixed-wing air ambulance transport.
- To explore how dexmedetomidine could improve patient care outcomes and enhance the safety of aircraft operations in this specific clinical context.
Main Methods:
- This study postulates the use of dexmedetomidine based on its known properties.
- A review of existing literature on sedatives used in air medical transport and TBI management was considered.
- The unique challenges of the air medical environment were analyzed in relation to sedative efficacy and safety.
Main Results:
- Dexmedetomidine is proposed as a viable alternative to current limited options for managing agitation in TBI patients during air transport.
- The drug's pharmacokinetic and pharmacodynamic profile suggests suitability for the prolonged and unique conditions of fixed-wing air ambulance missions.
- Improved patient sedation may lead to better tolerance of the transport environment and reduced physiological stress.
Conclusions:
- Dexmedetomidine presents a promising therapeutic option for enhancing patient care and safety during air medical transport of TBI patients.
- Further clinical investigation is warranted to confirm the efficacy and safety of dexmedetomidine in this specialized patient population and transport setting.
- Implementing dexmedetomidine could represent a significant advancement in the management of agitated TBI patients in fixed-wing air ambulances.
More Related Videos
Related Concept Videos
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Parenteral Anesthetics: Overview
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Skeletal Muscle Relaxants: Therapeutic Uses
Inhalational Anesthetics: Overview
Direct-Acting Cholinergic Agonists: Therapeutic Uses
![Studying Metabolic Brain Connectivity Using 2-Deoxy-2-[18F]Fluoro-D-Glucose Dynamic Positron Emission Tomography at the Single-subject Level](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F67458.jpg&w=3840&q=50)
